Glycemic Control, Glucose-Lowering Medication Use, and Utilization among Older Patients with Diabetes

被引:0
|
作者
Kuntz, Jennifer L.
Nichols, Gregory A.
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
301-OR
引用
收藏
页码:A79 / A80
页数:2
相关论文
共 50 条
  • [31] Racial Differences in Potential Overuse of Glucose-Lowering Medication among Older Adults: The Atherosclerosis Risk in Communities (ARIC) Study
    Lee, Alexandra K.
    Sharrett, A. Richey
    Windham, B. Gwen
    Huang, Elbert S.
    Selvin, Elizabeth
    DIABETES, 2016, 65 : A360 - A361
  • [32] Prior Glucose-Lowering Medication Use and 30-Day Outcomes Among 64,892 Veterans With Diabetes and COVID-19
    Wander, Pandora L.
    Lowy, Elliott
    Beste, Lauren A.
    Tulloch-Palomino, Luis
    Korpak, Anna
    Peterson, Alexander C.
    Kahn, Steven E.
    Boyko, Edward J.
    DIABETES CARE, 2021, 44 (12) : 2708 - 2713
  • [33] Inappropriate intensification of glucose-lowering treatment in older patients with type 2 diabetes: the global DISCOVER study
    Bongaerts, Brenda
    Arnold, Suzanne, V
    Charbonnel, Bernard H.
    Chen, Hungta
    Cooper, Andrew
    Fenici, Peter
    Gomes, Marilia
    Ji, Linong
    Khunti, Kamlesh
    Kosiborod, Mikhail
    Medina, Jesus
    Nicolucci, Antonio
    Shestakova, Marina
    Shimomura, Iichiro
    Tang, Fengming
    Watada, Hirotaka
    Rathmann, Wolfgang
    BMJ OPEN DIABETES RESEARCH & CARE, 2021, 9 (01)
  • [34] Glucose-lowering drug use and new-onset atrial fibrillation in patients with diabetes mellitus
    Fauchier, Gregoire
    Bisson, Arnaud
    Bodin, Alexandre
    Herbert, Julien
    Angoulvant, Denis
    Ducluzeau, Pierre Henri
    Lip, Gregory Y. H.
    Fauchier, Laurent
    DIABETOLOGIA, 2021, 64 (11) : 2602 - 2605
  • [35] Concomitant use of benzodiazepines and oral glucose-lowering drugs in patients with type-2 diabetes
    Fornero, Agostina
    Bertoldo, Pamela
    Dumont, Nilda
    FARMACEUTICOS COMUNITARIOS, 2018, 10 (01): : 41 - 46
  • [36] Glucose-lowering drug use and new-onset atrial fibrillation in patients with diabetes mellitus
    Gregoire Fauchier
    Arnaud Bisson
    Alexandre Bodin
    Julien Herbert
    Denis Angoulvant
    Pierre Henri Ducluzeau
    Gregory Y. H. Lip
    Laurent Fauchier
    Diabetologia, 2021, 64 : 2602 - 2605
  • [37] Diabetes knowledge, medication adherence and glycemic control among patients with type 2 diabetes
    Harith Kh. Al-Qazaz
    Syed A. Sulaiman
    Mohamed A. Hassali
    Asrul A. Shafie
    Shameni Sundram
    Rana Al-Nuri
    Fahad Saleem
    International Journal of Clinical Pharmacy, 2011, 33 : 1028 - 1035
  • [38] Diabetes knowledge, medication adherence and glycemic control among patients with type 2 diabetes
    Al-Qazaz, Harith Kh.
    Sulaiman, Syed A.
    Hassali, Mohamed A.
    Shafie, Asrul A.
    Sundram, Shameni
    Al-Nuri, Rana
    Saleem, Fahad
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2011, 33 (06) : 1028 - 1035
  • [39] Progression of glucose-lowering diabetes therapy in TECOS
    Bethel, M. Angelyn
    Engel, Samuel S.
    Stevens, Susanna R.
    Lokhnygina, Yuliya
    Ding, Jie
    Josse, Robert G.
    Alvarsson, Michael
    Hramiak, Irene
    Green, Jennifer B.
    Peterson, Eric D.
    Holman, Rury R.
    ENDOCRINOLOGY DIABETES & METABOLISM, 2019, 2 (01)
  • [40] Glucose-lowering medicines for type 2 diabetes
    Davoren, Peter
    AUSTRALIAN FAMILY PHYSICIAN, 2015, 44 (05) : 272 - 276